| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.002 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |